Cyteir Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyteir Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2023.
  • Cyteir Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -24.9 %, a 13.9% increase year-over-year.
  • Cyteir Therapeutics, Inc. annual Return On Equity for 2022 was -28.9 %, a 10.2% increase from 2021.
  • Cyteir Therapeutics, Inc. annual Return On Equity for 2021 was -32.1 %, a 163% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -24.9 +4.01 +13.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -28.9 -1.43 -5.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -29.7 -3.71 -14.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -28.9 +3.28 +10.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -28.9 +20.5 +41.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -27.5 +213 +88.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26 -74.2 -154% Jan 1, 2022 Mar 31, 2022
Q4 2021 -32.1 -82.9 -163% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.3 Jul 1, 2021 Sep 30, 2021
Q2 2021 -241 Apr 1, 2021 Jun 30, 2021
Q1 2021 48.2 Jan 1, 2021 Mar 31, 2021
Q4 2020 50.8 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.